BlackRock’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $460M | Sell |
|
|||||
|
2025
Q2 | $400M | Buy |
|
|||||
|
2025
Q1 | $411M | Sell |
|
|||||
|
2024
Q4 | $299M | Buy |
|
|||||
|
2024
Q3 | $305M | Buy |
|
|||||
|
2024
Q2 | $266M | Buy |
|
|||||
|
2024
Q1 | $255M | Sell |
|
|||||
|
2023
Q4 | $258M | Buy |
|
|||||
|
2023
Q3 | $205M | Buy |
|
|||||
|
2023
Q2 | $196M | Buy |
|
|||||
|
2023
Q1 | $152M | Sell |
|
|||||
|
2022
Q4 | $193M | Buy |
|
|||||
|
2022
Q3 | $97.8M | Sell |
|
|||||
|
2022
Q2 | $85.4M | Buy |
|
|||||
|
2022
Q1 | $86.6M | Sell |
|
|||||
|
2021
Q4 | $79.7M | Buy |
|
|||||
|
2021
Q3 | $68.2M | Sell |
|
|||||
|
2021
Q2 | $143M | Sell |
|
|||||
|
2021
Q1 | $131M | Buy |
|
|||||
|
2020
Q4 | $186M | Buy |
|
|||||
|
2020
Q3 | $161M | Sell |
|
|||||
|
2020
Q2 | $197M | Buy |
|
|||||
|
2020
Q1 | $133M | Buy |
|
|||||
|
2019
Q4 | $223M | Buy |
|
|||||
|
2019
Q3 | $36.7M | Buy |
|
|||||
|
2019
Q2 | $43.5M | Buy |
|
|||||
|
2019
Q1 | $6.63M | Buy |
|
|||||
|
2018
Q4 | $181K | Buy |
|
|||||
|
2018
Q3 | $193K | Buy |
|
|||||
|
2018
Q2 | $172K | Buy |
|
|||||
|
2018
Q1 | $115K | Sell |
|
|||||
|
2017
Q4 | $265K | Buy |
|
|||||
|
2017
Q3 | $251K | Sell |
|
|||||
|
2017
Q2 | $257K | Sell |
|
|||||
|
2017
Q1 | $1.92M | Buy |
|
|||||
|
2016
Q4 | $3K | Hold |
|
|||||
|
2016
Q3 | $3K | Hold |
|
|||||
|
2016
Q2 | $3K | Buy |
|